From professional translators, enterprises, web pages and freely available translation repositories.
3 17
3 535 000
Last Update: 2011-10-23
Usage Frequency: 9
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3 17 hovedafdelinger
nace rev. 1 17 sections
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
3/ 17 klimatiske forhold.
3/ 17 circumstances.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
lovvalg (artikel 3)17
freedom of choice (article 3)17
Last Update: 2017-04-06
Usage Frequency: 1
Quality:
børn og unge (3-17 år)
children and adolescents (3 to 17 years)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
den 3., 17. og 31. maj 2006
on 3, 17 and 31 may 2006,
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
den 3., 17. og 31. marts 2005
3, 17 and 31 march 2005,
Last Update: 2014-11-15
Usage Frequency: 1
Quality:
børn og teenagere i alderen 3-17 år:
children and adolescents 3-17 years of age:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmaceutiske oplysninger 3/ 17 6. 1 fortegnelse over hjælpestoffer
pharmaceutical particulars
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3-17 3-125 ordbog datamatik, informationssystem, ny teknologi, uddannelse
eec dublin foundation, information, new technology, technological change
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
3216 3 -17 udenrigspolitik arkiv, europæisk politisk samarbejde, fortegnelse, ministerium
publications of the european communities: july - september 1991
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
3/ 17 4. 10 overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt
three years for the panleucopenia component.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3/17 celler.antigenerne er inkorporerede i en adjuvans baseret på dl --tocopherol.
3/17 immunogens are incorporated in an adjuvant based on dl--tocopherol.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
bertset fra artikel 3, 17, 20-21, 27 og 32 finder af snit ii tilsvarende anvendelse på lokalt ansatte.
24, 27 and staff.
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
47, 90) af depocyte patienterne versus 3/ 17 (18% patienter, 95% sikkerhedsintervaller:
47, 90) of depocyte patients versus 3/ 17 (18% patients, 95% confidence intervals:
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
9 gennemsnitlige fordelingsvolumen 110, 3 ± 17, 9 ml/ kg og den gennemsnitlige halveringstid 11, 3 ± 3, 4 dage.
mean clearance was 0.31 ± 0.12 ml/hr/kg, mean volume of distribution was 110.3 ± 17.9 ml/kg, and mean elimination half-live was 11.3 ± 3.4 days.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
må jeg opfordre kommissionen og rådet til at acceptere de ændringsforslag, som vi skal stemme om i morgen, specielt ændringsforslag nr. 2, 3, 17 og 18.
may i urge the commission and council to accept the amendments which we shall be voting on tomorrow, in particular amendments nos 2, 3, 17 and 18.
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
tofoldsfortyndinger af antigen titreres over for en konstant fortynding (1:100) af monoklonalt antistof 3-17-a3.
twofold dilutions of antigen are titrated against a constant dilution (1/100) monoclonal antibody 3-17-a3.
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
patienterne var 3-17 år gamle med et aktivt polyartikulært forløb af børnegigt (jra) uanset starttype og ikke forud testet overfor methotrexate eller leflunomide.
patients were 317 years of age with active polyarticular course jra regardless of onset type and naive to methotrexate or leflunomide.
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
testprincippet er at afbryde reaktionen mellem btv-antigen og et gruppespecifikt monoklonalt antistof (3-17-a3) ved tilsætning af testserum.
the principle of the test is the interruption of the reaction between btv antigen and a group-specific monoclonal antibody (3-17-a3) by the addition of test serum.
Last Update: 2014-11-21
Usage Frequency: 3
Quality: